Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification.
Lung carcinomas are cytogenetically highly complex. In spite of this, patterns of recurrent chromosome aberrations have emerged. Apart from the frequent loss of 3p, losses of 4q, 5q, 8p, 9p, 10q, 13q, and 17p are common and gains often include 1q, 3q, 5p, and 8q. In the present study, we retrieved all aberrant lung carcinoma karyotypes, in total 432 cases, from the Mitelman Database of Chromosome Aberrations in Cancer and identified the most frequent imbalances. Each case was then classified with respect to the presence or absence of these imbalances and the data were statistically analyzed by means of principal component analysis, multidimensional scaling, and hierarchical cluster analysis. The analyses suggest that lung cancer develops through three pathways, initiated by +7, 3p-, and +12, respectively, and that the 3p- pathway is dominated by losses and the +12 pathway by gains. Gain of chromosome 7 was shown to be both important in the 3p- pathway and also forming a group of tumors containing +7 and +20 (with few additional changes). The distribution of the number of imbalances per tumor indicated that the karyotypic evolution might pass through three different phases. Phase I is characterized by tumors with few changes and by well-separated 3p- and +12 pathways. Phase II cases have an increased number of imbalances and exhibit less distinct 3p- and +12 pathways. Phase III tumors are polyploid and highly complex. No marked differences between the karyotypic profiles were found among morphologic subtypes, suggesting that lung cancer morphology is independent of the particular cytogenetic pathway operating in the tumor cells.
Höglund
Mattias
M
Department of Clinical Genetics, University Hospital, SE-221 85 Lund, Sweden. mattias.hoglund@klingen.lu.se
Gisselsson
David
D
Hansen
Gunnar B
GB
Mitelman
Felix
F
D000230:Adenocarcinoma / Q000235:genetics; D000782:Aneuploidy; D005075:Biological Evolution; D002294:Carcinoma, Squamous Cell / Q000235:genetics; D002869:Chromosome Aberrations; D002881:Chromosomes, Human, Pair 12; D002893:Chromosomes, Human, Pair 3; D002897:Chromosomes, Human, Pair 7; D016000:Cluster Analysis; D016208:Databases, Factual; D006801:Humans; D007621:Karyotyping; D008175:Lung Neoplasms / Q000145:classification / Q000235:genetics* / Q000473:pathology; D016305:Thymopentin; D013997:Time Factors
D016305:Thymopentin